Patient’s primary diagnosis: COPD.

The patient’s primary diagnosis is COPD. The spirometry data indicating an FEV1/FVC of .52, which meets the diagnosis criterion of FEV1/FVC<0.7 informed this diagnosis (Global Initiative for Chronic Obstructive Lung Disease [GOLD], 2020). Notably, the COPD is severe because the patient’s FEV1 was 47% of predicted which falls within the severe COPD range of 30%?FEV1>50% predicted (GOLD, 2020). Additionally, the patient presented with typical COPD symptoms, including progressive dyspnea that worsens with activity, chronic cough, sputum production, and wheeze (GOLD, 2020). This is incomplete. Prescription medications are NOT written appropriately as a RX .You wrote:I would recommend salbutamol metered-dose inhaler two puffs orally 4-6 hours as needed.I would also continue metoprolol succinate ER (Toprol-XL) 50 mg for hypertension. I would prescribe orlistat (Xenical) 120mg orally three times a day. Individualize your treatment plan as much as possibl​‌‍‍‍‌‍‍‌‍‌‌‍‍‍‌‍‌‌‌‍​e. Be very specific with the patient. In terms of what you are trying to teach the patient, please let him know how the information you are giving him will help him. What does the patient need to know about proper inhaler use technique? Incomplete problem list. For your follow up, you wrote: Follow-up in COPD is essential as it presents a crucial opportunity for treatment effectiveness evaluation. It is also an opportunity to monitor symptoms, exacerbations, and take objective airflow limitation measures, to determine the need to modify the treatment plan or identify complications or comorbidities. (GOLD, 2020). Therefore, asking the patient to adhere to follow-up visits is necessary.Incomplete f/u plan!No time frame included. The question asks:Are there any changes that you would also make to this patient’s overall treatment plan at this time? Must provide an EBP argument for each treatment or testing decision.You wrote:When an inappropriate response to treatment is observed, the treatment plan may change with GOLD (2020) recommending providers to adjust, review, and consider predominant treatable traits such as exacerbations and dyspnea and manage them accordingly.You did not answer the question. Please review the question and provide an answer? Dr.Of​‌‍‍‍‌‍‍‌‍‌‌‍‍‍‌‍‌‌‌‍​odile

Sample Solution